These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4479976)

  • 1. Effect of the pretreatment with some cytostatic agents on the growth rate of leukaemia L5178Y.
    Bohunickå E; Koza I; Ujhåzy V
    Neoplasma; 1974; 21(6):659-63. PubMed ID: 4479976
    [No Abstract]   [Full Text] [Related]  

  • 2. Alteration of SRBC immunogenicity by cytostatics (Ypenyl and Cytembena).
    Bohunická E; Ujházy V; Koza I
    Neoplasma; 1973; 20(6):695-7. PubMed ID: 4589743
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative studies of the cytostatic effect of a new N-Lost derivative "IMET 3393" and Endoxan in 3 experimental mice tumors (Ehrlich ascites carcinoma, sarcoma 180 solid, leukemia LAJ I)].
    Schnabel R; Jungstand W; Gutsche W; Grimm H; Fritsch S
    Acta Biol Med Ger; 1967; 19(4):543-58. PubMed ID: 5596676
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of effects of cyclophosphamide, Cytembena, and Ypenyl in the treatment of inoperable ovarian carcinoma.
    Skoda V; Elis J; Jandová A; Laurová L; Novotná J; Perlík F
    Neoplasma; 1971; 18(5):471-2. PubMed ID: 5165867
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic effectiveness of PTT-119 evaluated in vivo in experimental models].
    Bianchi R; Nardelli B; Allegrucci M; Fioretti MC
    G Ital Chemioter; 1985; 32(1):1-6. PubMed ID: 3830770
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cytostatic effect of vinylogous nitrogen mustard carbonamidium salts against transplanted tumors in an automatic preliminary test and a sequential test program].
    Gutsche W; Jungstand W; Wohlrabe K; Fischer GW; Lohs K
    Arch Geschwulstforsch; 1972; 39(2):121-7. PubMed ID: 5065117
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recent experimental researches on Peptichemio].
    De Barbieri A
    G Ital Chemioter; 1974; 21(1):2-4. PubMed ID: 4549578
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytostatic activity of an estradiol-linked nitrosourea in MXT mammary carcinoma and L 5222 leukemia.
    Zeller WJ; Schreiber J; Petru E; Eisenbrand G
    Arzneimittelforschung; 1989 Dec; 39(12):1577-9. PubMed ID: 2624608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of cytostatic alkylating agents on deoxyribonucleo protein complex of lymphatic and haemopoetic tissue.
    Matyásová J; Skalka M
    Neoplasma; 1966; 13(4):433-42. PubMed ID: 5921852
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacological studies with alkylsulfonyloxyalkyl substituted and chloroethyl substituted oxazaphosphorine-2-oxides. 2. Pharmacological characterization of 2-alkylsulfonyl-oxyalkylamino-oxazaphosphorine-2-oxides including immunological reaction].
    Arzneimittelforschung; 1974 Aug; 24(8):1149-60. PubMed ID: 4371545
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of cortiphen and cyclophosphamide in uterine sarcoma induced primarily by 1,2-dimethylhydrazine and estradiol dipropionate in CBA mice].
    Merkulova IB; Vvedenskaia NA; Kiselev VI
    Eksp Onkol; 1990; 12(1):68-70. PubMed ID: 2298148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The immunodepressive and lympholytic action of kortifen].
    Pykhtina AA; Gladkova NE
    Farmakol Toksikol; 1988; 51(5):72-4. PubMed ID: 3208888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of several immunomodulating agents on a model of humoral and cell mediated immunity in the mouse [proceedings].
    Bruin J; Cottney J; Gemmel DK; Lewis AJ
    Br J Pharmacol; 1979 May; 66(1):67P-68P. PubMed ID: 454953
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of the immunostimulatory activity of levamisole.
    Mantovani A; Spreafico F
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:302. PubMed ID: 4859247
    [No Abstract]   [Full Text] [Related]  

  • 15. Collateral sensitivity of resistant lines of mouse leukemias L1210 and L5178Y.
    Schmid FA; Hutchison DJ
    Cancer Res; 1972 Apr; 32(4):808-12. PubMed ID: 5014791
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunosuppressive effect of various cytostatics on humoral antibody formation].
    Potel J; Brock N
    Arzneimittelforschung; 1971 Aug; 21(8):1250-4. PubMed ID: 5110029
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis, acute toxicity and chemotherapeutic anti-cancer activities of a new tripeptidic mustard.
    De Barbieri A; Dall'Asta L; Comini A; Springolo V; Mosconi P; Coppi G
    Farmaco Sci; 1983 Apr; 38(4):205-18. PubMed ID: 6861998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopharmacological studies of PTT.119, a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative.
    Allegrucci M; Ballerini P; Romani L; Frati L
    Immunopharmacol Immunotoxicol; 1987; 9(1):71-86. PubMed ID: 3450712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bendamustine (Treanda) for CLL and NHL.
    Med Lett Drugs Ther; 2008 Nov; 50(1299):91-2. PubMed ID: 19008789
    [No Abstract]   [Full Text] [Related]  

  • 20. Preclinical studies on NSC290205 aza-steroid alkylator activity in combination with adriamycin against lymphoid leukaemia.
    Trafalis DT; Tsavdaridis D; Camoutsis C; Karayiani V; Mourelatos D; Dalezis P; Athanassiou A; Pangalis GA; Papageorgiou A
    Br J Haematol; 2005 Feb; 128(3):343-50. PubMed ID: 15667536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.